Deletion of thioredoxin-interacting protein in mice impairs mitochondrial function but protects the myocardium from ischemia-reperfusion injury
Jun Yoshioka(City University of New York), Richard Lee(City of Hope), Edward P. Feener(KalVista Pharmaceuticals (United States)), Rong Tian(Nanjing University of Chinese Medicine), Merry L. Lindsey(Meharry Medical College), Jae Bum Kim(Lehigh University), William A. Chutkow(Novartis (United States)), Samuel Lee(University of Cologne), Christine E. Seidman(Harvard University), Jie Yan(Harvard University Press), Jonathan G. Seidman(Harvard University)
Cited by 157
Related Papers
Contemporary Definitions and Classification of the Cardiomyopathies
|Circulation|2006|3.4k
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
|Circulation|2011|2.1k
Cells of the adult human heart
|Nature|2020|1.8k
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy
|Journal of the American College of Cardiology|2003|1.6k